Response of hormone refractory prostate cancer to lycopene

被引：4
|
作者：
Kucuk, O [1 ]
Wood, DP [1 ]
机构：
[1] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Dept Med, Detroit, MI 48202 USA
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 02期
关键词：
D O I：
10.1016/S0022-5347(01)69112-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：651 / 651
页数：1
相关论文
共 50 条
  • [11] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [12] The management of hormone refractory prostate cancer
    Newling, DWW
    EUROPEAN UROLOGY, 1996, 29 : 69 - 74
  • [13] Chemotherapy of hormone refractory prostate cancer
    Wirth, MP
    Nippgen, J
    UROLOGE A, 2003, 42 (11): : 1453 - +
  • [14] Chemotherapy for hormone refractory prostate cancer
    Smith, DC
    UROLOGIC CLINICS OF NORTH AMERICA, 1999, 26 (02) : 323 - +
  • [15] Overview: Hormone refractory prostate cancer
    Crawford, ED
    Rosenblum, M
    Ziada, AM
    Lange, PH
    UROLOGY, 1999, 54 (6A) : 1 - 7
  • [16] Androstenedione Is the Preferred Androgen Source in Hormone Refractory Prostate Cancer-Response
    Hovens, Christopher M.
    Hong, Matthew K. H.
    Corcoran, Niall M.
    CLINICAL CANCER RESEARCH, 2014, 20 (18) : 4972 - 4973
  • [17] Management of the spectrum of hormone refractory prostate cancer
    Clarke, Noel W.
    EUROPEAN UROLOGY, 2006, 50 (03) : 428 - 439
  • [18] Taxanes in hormone-refractory prostate cancer
    Kang, MH
    Figg, WD
    Dahut, W
    CANCER PRACTICE, 1999, 7 (05) : 270 - 272
  • [19] Chemotherapy for advanced hormone refractory prostate cancer
    Petrylak, DP
    UROLOGY, 1999, 54 (6A) : 30 - 35
  • [20] Systemic treatment of hormone refractory prostate cancer
    H. Rübben
    A. Bex
    T. Otto
    World Journal of Urology, 2001, 19 : 99 - 110
12345